Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Varex Imaging Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$15.90 |
52 Week High | US$23.90 |
52 Week Low | US$14.55 |
Beta | 0.72 |
1 Month Change | 1.99% |
3 Month Change | -6.19% |
1 Year Change | -27.73% |
3 Year Change | -37.25% |
5 Year Change | -43.44% |
Change since IPO | -41.69% |
Recent News & Updates
Recent updates
We Like Varex Imaging's (NASDAQ:VREX) Earnings For More Than Just Statutory Profit
May 10Varex Imaging Corporation: The Picture Is Cloudy After Quarterly Results
Feb 07We Like These Underlying Return On Capital Trends At Varex Imaging (NASDAQ:VREX)
Dec 14Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Nov 05Is There Now An Opportunity In Varex Imaging Corporation (NASDAQ:VREX)?
Oct 29Varex Imaging (NASDAQ:VREX) Hasn't Managed To Accelerate Its Returns
Sep 27What Is Varex Imaging Corporation's (NASDAQ:VREX) Share Price Doing?
Jul 21These 4 Measures Indicate That Varex Imaging (NASDAQ:VREX) Is Using Debt Reasonably Well
Jun 15Is It Too Late To Consider Buying Varex Imaging Corporation (NASDAQ:VREX)?
Mar 25Varex Imaging Corporation's (NASDAQ:VREX) CEO Might Not Expect Shareholders To Be So Generous This Year
Feb 04Is Varex Imaging (NASDAQ:VREX) A Risky Investment?
Jan 31Returns On Capital At Varex Imaging (NASDAQ:VREX) Paint A Concerning Picture
Dec 22What Does Varex Imaging Corporation's (NASDAQ:VREX) Share Price Indicate?
Nov 08Varex Imaging (NASDAQ:VREX) Has A Pretty Healthy Balance Sheet
Oct 11Investors Could Be Concerned With Varex Imaging's (NASDAQ:VREX) Returns On Capital
Sep 01Varex Imaging Corporation Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 06Varex Imaging: Low-Growth X-Ray Imaging Component Provider Offers Stable Upside
Jun 20What Is Varex Imaging Corporation's (NASDAQ:VREX) Share Price Doing?
Jun 07Varex Imaging (NASDAQ:VREX) Is Making Moderate Use Of Debt
May 11Varex Imaging Corporation 2021 Q2 - Results - Earnings Call Presentation
May 06Don't Ignore The Fact That This Insider Just Sold Some Shares In Varex Imaging Corporation (NASDAQ:VREX)
Mar 05Varex Imaging Corporation 2021 Q1 - Results - Earnings Call Presentation
Feb 05Shareholder Returns
VREX | US Medical Equipment | US Market | |
---|---|---|---|
7D | 7.5% | -0.8% | -0.6% |
1Y | -27.7% | 1.9% | 22.5% |
Return vs Industry: VREX underperformed the US Medical Equipment industry which returned 1.9% over the past year.
Return vs Market: VREX underperformed the US Market which returned 22.5% over the past year.
Price Volatility
VREX volatility | |
---|---|
VREX Average Weekly Movement | 3.6% |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 5.8% |
10% most volatile stocks in US Market | 15.7% |
10% least volatile stocks in US Market | 2.9% |
Stable Share Price: VREX has not had significant price volatility in the past 3 months.
Volatility Over Time: VREX's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | 2,300 | Sunny Sanyal | www.vareximaging.com |
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Varex Imaging Corporation Fundamentals Summary
VREX fundamental statistics | |
---|---|
Market cap | US$631.22m |
Earnings (TTM) | US$41.90m |
Revenue (TTM) | US$855.80m |
15.5x
P/E Ratio0.8x
P/S RatioIs VREX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VREX income statement (TTM) | |
---|---|
Revenue | US$855.80m |
Cost of Revenue | US$578.60m |
Gross Profit | US$277.20m |
Other Expenses | US$235.30m |
Earnings | US$41.90m |
Last Reported Earnings
Mar 29, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.03 |
Gross Margin | 32.39% |
Net Profit Margin | 4.90% |
Debt/Equity Ratio | 75.0% |
How did VREX perform over the long term?
See historical performance and comparison